SCHEMBL7380397

SCHEMBL7380397

CC(C)(C)OC(=O)CC(c1ccccc1)c1ccc(NC(=O)c2cccc(NC(=N)N)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASR P41180 1/20 0.47
NPC1 O15118 3/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
ITGB3 P05106 2/20 0.46
ITGA2B P08514 2/20 0.46
POLB P06746 1/20 0.46
ITGB1 P05556 1/20 0.43
ITGAV P06756 1/20 0.43
ITGB5 P18084 1/20 0.43
STAT3 P40763 1/20 0.43
RAB9A P51151 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
PLK4 O00444 1/20 0.42
CHEK1 O14757 1/20 0.42
AURKA O14965 1/20 0.42
CHUK O15111 1/20 0.42
DAPK3 O43293 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7379927 0.89 KMT2A (0.45) NPC1KMT2AMEN1ITGB3ITGA2B
SCHEMBL7856438 0.87 CASR (0.49) CASRNPC1KMT2AMEN1POLB
SCHEMBL7455765 0.85 ITGB3 (0.58) NPC1KMT2AMEN1ITGB3ITGA2B
SCHEMBL7375285 0.85 KMT2A (0.44) NPC1KMT2AMEN1ITGB3ITGA2B
SCHEMBL8431172 0.82 MAPT (0.46) CASRNPC1KMT2AMEN1ITGB3
SCHEMBL7452939 0.81 KMT2A (0.41) NPC1KMT2AMEN1ITGB3ITGA2B
SCHEMBL7856433 0.80 ITGB3 (0.54) NPC1KMT2AMEN1ITGB3ITGA2B
SCHEMBL7452316 0.78 ITGB3 (0.57) NPC1KMT2AMEN1ITGB3ITGA2B
SCHEMBL7856471 0.77 TP53 (0.45) CASRKMT2AMEN1MAPTHTT
SCHEMBL6778195 0.77 ITGB3 (0.43) CASRKMT2AMEN1ITGB3ITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0891325-B1 PARA-SUBSTITUTED PHENYLPROPANOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2002-02-06 EP claimed
EP-1157985-A1 Para- substituted phenylene derivatives and their use as integrin antagonists G.D. SEARLE & CO. (US) 2001-11-28 EP claimed
US-6251944-B1 (VITRONECTIN RECEPTOR) INTEGRIN ANTAGONIST, USEFUL FOR TREATING ANGIOGENESIS, TUMOR GROWTH, TUMOR METASTASIS, OSTEOPOROSIS AND HUMORAL HYPERCALCEMIA OF MALIGNANCY G. D. SEARLE & COMPANY 2001-06-26 US claimed
EP-0891325-A1 PARA-SUBSTITUTED PHENYLPROPANOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1999-01-20 EP claimed
WO-1997036859-A1 PARA-SUBSTITUTED PHENYLPROPANOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1997-10-09 WO claimed
EP-0891325-B1 PARA-SUBSTITUTED PHENYLPROPANOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2002-02-06 EP disclosed
EP-1157985-A1 Para- substituted phenylene derivatives and their use as integrin antagonists G.D. SEARLE & CO. (US) 2001-11-28 EP disclosed
US-6251944-B1 (VITRONECTIN RECEPTOR) INTEGRIN ANTAGONIST, USEFUL FOR TREATING ANGIOGENESIS, TUMOR GROWTH, TUMOR METASTASIS, OSTEOPOROSIS AND HUMORAL HYPERCALCEMIA OF MALIGNANCY G. D. SEARLE & COMPANY 2001-06-26 US disclosed